IPC and Uttar Pradesh Promote Pharma Council Sign MoU to Strengthen Healthcare Quality and Regulatory Standards
The Indian Pharmacopoeia Commission and the Uttar Pradesh Promote Pharma Council have signed a Memorandum of Understanding to strengthen healthcare quality standards, promote regulatory excellence, support innovation, encourage research, and enhance collaboration through training programmes and capacity-building initiatives across the pharmaceutical and medical device sectors in India.
The MoU aims to strengthen the pharmaceutical and medical device ecosystem by encouraging the adoption of quality standards, enhancing regulatory excellence, supporting innovation, and building institutional capacity. Under the partnership, IPC and UPPPC will work together to promote research, drive innovation, and encourage collaboration between industry and academic institutions.
As part of the agreement, both organizations will jointly organize training programmes, workshops, and other capacity-building initiatives to improve technical expertise and strengthen the overall healthcare ecosystem. The collaboration is expected to create a stronger framework for knowledge sharing and professional development within the pharmaceutical and medical device sectors.
The Ministry of Health and Family Welfare stated that the MoU reflects IPC's continued commitment to advancing high-quality healthcare standards, supporting innovation, and strengthening India's regulatory framework. The partnership highlights a coordinated effort to enhance quality, encourage research, and reinforce the country's pharmaceutical and medical device ecosystem through sustained collaboration.

Comment List